Continuous glucose monitoring is a significant benefit in care of patients with diabetes. By using CGM systems, a variety of new parameters, such as "glucose management indicator " (GMI), were established to describe glycaemic control of patients.
GMI can in some ways imitate glycated haemoglobin, but is not always easily interchangeable.